Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prof. Uriel Martinowitz, Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00284193
First received: January 17, 2006
Last updated: July 26, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)